4//SEC Filing
Arno Therapeutics, Inc 4
Accession 0000914190-13-000757
CIK 0001195116operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 7:47 PM ET
Size
14.7 KB
Accession
0000914190-13-000757
Insider Transaction Report
Form 4
HAMILTON WILLIAM F PHD
Director
Transactions
- Purchase
Common Stock
2013-10-29+20,833→ 22,079 total - Purchase
2013 Series D Warrants (right to buy)
2013-10-29+20,833→ 20,833 totalExercise: $4.00From: 2013-10-29Exp: 2018-10-29→ Common Stock (20,833 underlying) - Purchase
2013 Series E Warrants (right to buy)
2013-10-29+20,833→ 20,833 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (20,833 underlying)
Holdings
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2019-09-29→ Common Stock (3,750 underlying) - 1,250
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (1,250 underlying)
Footnotes (3)
- [F1]The reported securities are included within 20,833 Issuer units purchased by the Reporting Person for $2.40 per unit. Each unit consists of one share of common stock, a 2013 Series D Warrant to purchase one share of common stock, and a 2013 Series E Warrant to purchase one share of common stock.
- [F2]Currently exercisable.
- [F3]Vests in three equal annual installments commencing 11/5/11.
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001195116
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 7:47 PM ET
- Size
- 14.7 KB